• Home  
  • A kill switch for epilepsy? China cuts seizures by 92.6% in first human chemogenetic trial
A kill switch for epilepsy? China cuts seizures by 92.6% in first human chemogenetic trial
- Asia

A kill switch for epilepsy? China cuts seizures by 92.6% in first human chemogenetic trial

For people living with refractory epilepsy, the brain is like a city that can suffer a blackout any time lightning strikes. Without warning, an abnormal neural discharge can sweep through the intracranial circuits, leaving behind convulsions, loss of consciousness and years of lingering panic. Around one-third of epilepsy patients worldwide are completely unresponsive to existing


For people living with refractory epilepsy, the brain is like a city that can suffer a blackout any time lightning strikes.
Without warning, an abnormal neural discharge can sweep through the intracranial circuits, leaving behind convulsions, loss of consciousness and years of lingering panic.
Around one-third of epilepsy patients worldwide are completely unresponsive to existing medications, while traditional craniotomy resection surgery often carries the risk of irreversible neurological…

Source: www.scmp.com

About Us

Pleskmedia Media Is a Global News Platform Covering the Latest Developments and Breaking Stories from Around The World, Including World News, Business, Finance, Technology, Health, Politics, Science, Entertainment, Sports, and More.

Pleskmedia
PleskMedia @2026. All Rights Reserved.